Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
103 - If we have a non-branded poster, talking about a disease and with a call to action: talk to your doctor. This poster will be given to the secretary of the doctor's office by the pharmaceutical representative and then will be posted in the examining room. Is this subject to PAAB review? Also with the poster there will be a booklet disease oriented for patients also to be given to secretary to be left in the examining room. Is this subject to PAAB review? With that poster there will be a card to be given to the patient by the doctor with the same message and a call to action (talk to your doctor) is this also subject to PAAB review?
-
The PAAB generally reviews APS which discuss drug therapy. Product branded and unbranded service oriented vehicles such as posters intended for the examination room and cards/brochures intended to be distributed to patients through health care professionals are reviewed under PAAB code s6. Note that the absence of product branding would not, in of itself, render an APS exempt. You may refer to PAAB code 6 for exemptions. If you would like further information about your specific pieces, please call the PAAB office.
